You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • THU0691 Is serum amyloid a protein an useful biomarker to monitor treatment with anti-tumour necrosis factor-alpha agents in spondyloarthritis patients?

Alerts

Article menu

Download PDFPDF

Poster Presentations
Validation of outcome measures and biomarkers
THU0691 Is serum amyloid a protein an useful biomarker to monitor treatment with anti-tumour necrosis factor-alpha agents in spondyloarthritis patients?
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address